Gut microbiota and pediatric metabolic dysfunction–associated steatotic liver disease: clinical evidence and therapeutic implications - Top-Institutions - MDSpire

Gut microbiota and pediatric metabolic dysfunction–associated steatotic liver disease: clinical evidence and therapeutic implications

By
Bhagyalakshmi Nair
Adithya Jayaprakash Kamath
Aswathy R. Devan
Rajesh Gopalakrishna
Ashok R. Unni
Lekshmi R. Nath
May 13, 2026
0 min

Frontiers In Pediatrics

Share

Top Institutions in Pediatrics

Brief introduction explaining scope and methodology.

#1

Cincinnati Children’s Hospital Medical Center

Cincinnati, Ohio
Key Differentiators
- Pediatric Gastroenterology
- Pediatric Hepatology
#2

Children’s Hospital of Philadelphia

Philadelphia, Pennsylvania
Key Differentiators
- Pediatric Gastroenterology
- Pediatric Hepatology
#3

Mayo Clinic

Rochester, Minnesota
Key Differentiators
- Pediatric Gastroenterology
#4

Shenzhen Children’s Hospital

Shenzhen, Guangdong
Key Differentiators
- Pediatric Gastroenterology
#5

Virginia Commonwealth University School of Medicine

Richmond, Virginia
Key Differentiators
- Pediatric Gastroenterology

Original Source(s)

Frontiers In Pediatrics

Gut microbiota and pediatric metabolic dysfunction–associated steatotic liver disease: clinical evidence and therapeutic implications

by Bhagyalakshmi Nair, Adithya Jayaprakash Kamath, Aswathy R. Devan, Rajesh Gopalakrishna, Ashok R. Unni, Lekshmi R. Nath
May 13, 2026

Related Content

Frontiers In Pediatrics

Comparative evaluation of SBS and RASS for sedation assessment in mechanically ventilated children

by Dan Li, Shan He, Qi Li, Jie Shen, Ping Tang
May 25, 2026

Frontiers In Endocrinology

Secular trends in HbA1c levels among children and adolescents with type 1 diabetes

Frontiers In Pediatrics

Case Report: Acute myeloid leukemia with mixed immunophenotypic features and TCF3::ZNF384 fusion in a pediatric patient with CNS involvement: a diagnostic and therapeutic challenge